Lisa Cabott Carson - 05 Feb 2026 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Chief Financial Officer
Signature
/s/ Lisa C. Carson
Issuer symbol
PHIO
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
4
Filing time
06 Feb 2026, 07:58:27 UTC
Previous filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carson Lisa Cabott Chief Financial Officer C/O PHIO PHARMACEUTICALS CORP, 411 SWEDELAND RD., STE 23-1080, KING OF PRUSSIA /s/ Lisa C. Carson 06 Feb 2026 0002073513

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $.0001 par value Award $0 +47,000 +100% $0.000000 94,000 05 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
F2 Includes shares of common stock underlying unvested restricted stock units.